{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:30:17Z","timestamp":1789587017249,"version":"build-2803163510"},"reference-count":139,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UKRI MRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jpet.2026.104936","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:58:29Z","timestamp":1778284709000},"page":"104936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Arginine vasopressin: A promising therapeutic target for metabolic syndrome"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7750-2450","authenticated-orcid":false,"given":"Ghadir","family":"Elsamad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed I.","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim S.","family":"Echtay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2946-0353","authenticated-orcid":false,"given":"David","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.jpet.2026.104936_bib1","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","article-title":"Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus","volume":"112","author":"Wilson","year":"2005","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.jpet.2026.104936_bib2","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.jpet.2026.104936_bib3","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12889-017-4041-1","article-title":"Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review","volume":"17","author":"Ranasinghe","year":"2017","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.jpet.2026.104936_bib5","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.dsx.2020.05.043","article-title":"Prevalence of metabolic syndrome by different definitions, and its association with type 2 diabetes, pre-diabetes, and cardiovascular disease risk in Brazil","volume":"14","author":"do Vale Moreira","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/2230-8210.91193","article-title":"Metabolic syndrome in the Middle East","volume":"16","author":"Sliem","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.jpet.2026.104936_bib7","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.4236\/health.2013.510227","article-title":"Prevalence of metabolic syndrome in type 2 diabetic patients: a comparative study using WHO, NCEP ATP III, IDF and Harmonized definitions","volume":"5","author":"Tan","year":"2013","journal-title":"Health"},{"issue":"3","key":"10.1016\/j.jpet.2026.104936_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S2352-4642(21)00374-6","article-title":"Global, regional, and country estimates of metabolic syndrome burden in children and adolescents in 2020: a systematic review and modelling analysis","volume":"6","author":"Noubiap","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"24","key":"10.1016\/j.jpet.2026.104936_bib9","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1001\/jama.2020.4501","article-title":"Trends in the prevalence of metabolic syndrome in the United States, 2011-2016","volume":"323","author":"Hirode","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jpet.2026.104936_bib10","doi-asserted-by":"crossref","DOI":"10.5888\/pcd17.200020","article-title":"The influence of metabolic syndrome in predicting mortality risk among US adults: importance of metabolic syndrome even in adults with normal weight","volume":"17","author":"Shi","year":"2020","journal-title":"Prev Chronic Dis"},{"issue":"11","key":"10.1016\/j.jpet.2026.104936_bib11","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.3390\/nu11112628","article-title":"Sleep apnea and sleep habits: relationships with metabolic syndrome","volume":"11","author":"Borel","year":"2019","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.jpet.2026.104936_bib12","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2337\/dc12-0336","article-title":"Metabolic syndrome and risk of cancer: a systematic review and meta-analysis","volume":"35","author":"Esposito","year":"2012","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.jpet.2026.104936_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002710","article-title":"Metabolic syndrome in pregnancy and risk for adverse pregnancy outcomes: a prospective cohort of nulliparous women","volume":"15","author":"Grieger","year":"2018","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.jpet.2026.104936_bib14","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/ijms23020786","article-title":"Metabolic syndrome: updates on pathophysiology and management in 2021","volume":"23","author":"Fahed","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","article-title":"Trends in insulin resistance: insights into mechanisms and therapeutic strategy","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.jpet.2026.104936_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11892-018-1101-6","article-title":"Pathogenesis of lipid disorders in insulin resistance: a brief review","volume":"18","author":"Bjornstad","year":"2018","journal-title":"Curr Diab Rep"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/metabo13010087","article-title":"Links between metabolic syndrome and hypertension: the relationship with the current antidiabetic drugs","volume":"13","author":"Stanciu","year":"2023","journal-title":"Metabolites"},{"issue":"6","key":"10.1016\/j.jpet.2026.104936_bib18","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/cen.13235","article-title":"Copeptin in obese children and adolescents: relationships to body mass index, cortisol and gender","volume":"85","author":"Rothermel","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.jpet.2026.104936_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-20-0077","article-title":"In adults with obesity, copeptin is linked with BMI but is not associated with long-term exposure to cortisol and cortisone","volume":"183","author":"van der Valk","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00431-020-03777-3","article-title":"Distribution of plasma copeptin levels and influence of obesity in children and adolescents","volume":"180","author":"Tuli","year":"2021","journal-title":"Eur J Pediatr"},{"issue":"19","key":"10.1016\/j.jpet.2026.104936_bib21","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1161\/CIRCULATIONAHA.109.909663","article-title":"Plasma copeptin and the risk of diabetes mellitus","volume":"121","author":"Enh\u00f6rning","year":"2010","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jpet.2026.104936_bib22","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.arcmed.2020.05.018","article-title":"Relation of copeptin with diabetic and renal function markers among patients with diabetes mellitus progressing towards diabetic nephropathy","volume":"51","author":"Noor","year":"2020","journal-title":"Arch Med Res"},{"issue":"4","key":"10.1016\/j.jpet.2026.104936_bib23","article-title":"Increased copeptin levels in metabolic syndrome from a Romanian population","volume":"9","author":"Vintil\u0103","year":"2016","journal-title":"J Med Life"},{"issue":"8","key":"10.1016\/j.jpet.2026.104936_bib24","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/HJH.0000000000000610","article-title":"Plasma copeptin levels and ambulatory blood pressure characteristics in healthy adults","volume":"33","author":"Schoen","year":"2015","journal-title":"J Hypertens"},{"issue":"7","key":"10.1016\/j.jpet.2026.104936_bib25","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1210\/jc.2008-2278","article-title":"Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome","volume":"94","author":"Saleem","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jpet.2026.104936_bib26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.5603\/EP.a2021.0072","article-title":"Copeptin as a novel biomarker of cardiometabolic syndrome","volume":"72","author":"Szmygin","year":"2021","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.jpet.2026.104936_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.901990","article-title":"Copeptin as a diagnostic and prognostic biomarker in cardiovascular diseases","volume":"9","author":"Mu","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.jpet.2026.104936_bib28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ijo.2012.88","article-title":"Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malm\u00f6 Diet and Cancer Study cardiovascular cohort","volume":"37","author":"Enh\u00f6rning","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jpet.2026.104936_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5237903","article-title":"Association between copeptin and metabolic syndrome: a systematic review","volume":"2022","author":"Rojas-Humpire","year":"2022","journal-title":"J Nutr Metab"},{"issue":"4","key":"10.1016\/j.jpet.2026.104936_bib30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ahj.2014.11.020","article-title":"Copeptin is an independent predictor of diabetic heart disease and death","volume":"169","author":"Enh\u00f6rning","year":"2015","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.jpet.2026.104936_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/heartjnl-2015-308183","article-title":"Copeptin predicts coronary artery disease cardiovascular and total mortality","volume":"102","author":"Tasevska","year":"2016","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.jpet.2026.104936_bib32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/hr.2016.165","article-title":"Copeptin as a biomarker for prediction of prognosis of acute ischemic stroke and transient ischemic attack: a meta-analysis","volume":"40","author":"Xu","year":"2017","journal-title":"Hypertens Res"},{"issue":"9","key":"10.1016\/j.jpet.2026.104936_bib33","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/jcmm.13102","article-title":"Predictive value of plasma copeptin level for the risk and mortality of heart failure: a meta-analysis","volume":"21","author":"Yan","year":"2017","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1465-9921-14-130","article-title":"Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension","volume":"14","author":"Nickel","year":"2013","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/biomedicines9010089","article-title":"The biology of vasopressin","volume":"9","author":"Sparapani","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib36","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12020-021-02830-x","article-title":"Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred","volume":"74","author":"Marzocchi","year":"2021","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.jpet.2026.104936_bib37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1210\/jc.2017-01891","article-title":"Release and decay kinetics of copeptin vs AVP in response to osmotic alterations in healthy volunteers","volume":"103","author":"Fenske","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jpet.2026.104936_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2826.1999.00308.x","article-title":"Rapid and sensitive vasopressin heteronuclear RNA responses to changes in plasma osmolality","volume":"11","author":"Arima","year":"1999","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104936_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1994.1007","article-title":"Baroreceptor regulation of vasopressin and renin secretion: low-pressure versus high-pressure receptors","volume":"15","author":"Thrasher","year":"1994","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.jpet.2026.104936_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.744177","article-title":"Vasopressin and breathing: review of evidence for respiratory effects of the antidiuretic hormone","volume":"12","author":"Proczka","year":"2021","journal-title":"Front Physiol"},{"issue":"4 Pt 1","key":"10.1016\/j.jpet.2026.104936_bib41","first-page":"E538","article-title":"Effect of insulin on osmoregulation of vasopressin","volume":"252","author":"Vokes","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jpet.2026.104936_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/bs.vh.2019.08.017","article-title":"Vasopressin inactivation: role of insulin-regulated aminopeptidase","volume":"113","author":"Li","year":"2020","journal-title":"Vitam Horm"},{"issue":"6","key":"10.1016\/j.jpet.2026.104936_bib43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000054557","article-title":"Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin","volume":"71","author":"Morimoto","year":"2000","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.jpet.2026.104936_bib44","doi-asserted-by":"crossref","first-page":"E1289","DOI":"10.1152\/ajpendo.90489.2008","article-title":"Interleukin-6 activates arginine vasopressin neurons in the supraoptic nucleus during immune challenge in rats","volume":"296","author":"Palin","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.jpet.2026.104936_bib45","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2826.2009.01879.x","article-title":"Interleukin-6 gene knockout influences energy balance regulating peptides in the hypothalamic paraventricular and supraoptic nuclei","volume":"21","author":"Benrick","year":"2009","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104936_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000322238","article-title":"Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation","volume":"118","author":"Swart","year":"2011","journal-title":"Nephron Physiol"},{"issue":"12","key":"10.1016\/j.jpet.2026.104936_bib47","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jcmg.2014.07.017","article-title":"Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study","volume":"7","author":"Shah","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6220","key":"10.1016\/j.jpet.2026.104936_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"issue":"31","key":"10.1016\/j.jpet.2026.104936_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2169","article-title":"A single-cell type transcriptomics map of human tissues","volume":"7","author":"Karlsson","year":"2021","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.jpet.2026.104936_bib51","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3390\/nu14040797","article-title":"Association between adipose tissue depots and dyslipidemia: the KORA-MRI population-based study","volume":"14","author":"von Kr\u00fcchten","year":"2022","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.jpet.2026.104936_bib52","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","article-title":"Non-alcoholic fatty liver disease and dyslipidemia: an update","volume":"65","author":"Katsiki","year":"2016","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.jpet.2026.104936_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.molmet.2013.12.006","article-title":"AVP neurons in the paraventricular nucleus of the hypothalamus regulate feeding","volume":"3","author":"Pei","year":"2014","journal-title":"Mol Metab"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16049-2","article-title":"Activation of endogenous arginine vasopressin neurons inhibit food intake: by using a novel transgenic rat line with DREADDs system","volume":"7","author":"Yoshimura","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jpet.2026.104936_bib55","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1113\/expphysiol.1989.sp003294","article-title":"Vasopressin reduces food intake in goats","volume":"74","author":"Meyer","year":"1989","journal-title":"Q J Exp Physiol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0031-9384(91)90251-I","article-title":"Mechanisms of vasopressin\u2019s anorectic effect","volume":"49","author":"Langhans","year":"1991","journal-title":"Physiol Behav"},{"issue":"4","key":"10.1016\/j.jpet.2026.104936_bib57","doi-asserted-by":"crossref","first-page":"E478","DOI":"10.1152\/ajpendo.00338.2016","article-title":"Suprachiasmatic vasopressin to paraventricular oxytocin neurocircuit in the hypothalamus relays light reception to inhibit feeding behavior","volume":"315","author":"Santoso","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12576-021-00802-4","article-title":"Chemogenetic activation of endogenous arginine vasopressin exerts anorexigenic effects via central nesfatin-1\/NucB2 pathway","volume":"71","author":"Sanada","year":"2021","journal-title":"J Physiol Sci"},{"key":"10.1016\/j.jpet.2026.104936_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170555","article-title":"Arginine vasopressin: direct and indirect action on metabolism","volume":"142","author":"Yoshimura","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.jpet.2026.104936_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2021.111385","article-title":"Dehydration and loss of appetite: key nutrition features in older people receiving home health care","author":"Engelheart","year":"2021","journal-title":"Nutrition"},{"key":"10.1016\/j.jpet.2026.104936_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101692","article-title":"Osmoadaptive GLP-1R signalling in hypothalamic neurones inhibits antidiuretic hormone synthesis and release","volume":"70","author":"Greenwood","year":"2023","journal-title":"Mol Metab"},{"issue":"2\u20133","key":"10.1016\/j.jpet.2026.104936_bib62","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.regpep.2010.05.016","article-title":"Arginine-vasopressin directly promotes a thermogenic and pro-inflammatory adipokine expression profile in brown adipocytes","volume":"164","author":"K\u00fcchler","year":"2010","journal-title":"Regul Pept"},{"key":"10.1016\/j.jpet.2026.104936_bib63","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1152\/ajplegacy.1964.207.5.1166","article-title":"Effect of pitressin on lipolysis and on phosphorylase activity in rat adipose tissue","volume":"207","author":"Vaughan","year":"1964","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jpet.2026.104936_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2015.02.009","article-title":"Arginine vasopressin inhibits adipogenesis in human adipose-derived stem cells","volume":"406","author":"Tran","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/bj2120231","article-title":"Metabolic effects of vasopressin infusion in the starved rat. Reversal of ketonaemia","volume":"212","author":"Rofe","year":"1983","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1210\/me.2006-0069","article-title":"Hypermetabolism of fat in V1a vasopressin receptor knockout mice","volume":"21","author":"Hiroyama","year":"2007","journal-title":"Mol Endocrinol"},{"issue":"2\u20133","key":"10.1016\/j.jpet.2026.104936_bib67","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejphar.2008.11.043","article-title":"Altered lipid metabolism in vasopressin V1B receptor-deficient mice","volume":"602","author":"Hiroyama","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"10.1016\/j.jpet.2026.104936_bib68","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2009.04.008","article-title":"Both V(1A) and V(1B) vasopressin receptors deficiency result in impaired glucose tolerance","volume":"613","author":"Nakamura","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104936_bib69","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/ijms20030759","article-title":"Insulin and insulin receptors in adipose tissue development","volume":"20","author":"Cignarelli","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jpet.2026.104936_bib70","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1507\/endocrj.47.557","article-title":"A clinical feature of hyperlipidemia in patients with central diabetes insipidus","volume":"47","author":"Takahashi-Tezuka","year":"2000","journal-title":"Endocr J"},{"issue":"11S","key":"10.1016\/j.jpet.2026.104936_bib71","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.20223311S1160d","article-title":"Fuster Research Team. Altered lipid metabolism in autosomal dominant polycystic kidney disease patients treated with tolvaptan: TH-PO409","volume":"33","author":"Bargagli","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"77 Pt 1","key":"10.1016\/j.jpet.2026.104936_bib72","first-page":"141","article-title":"Inhibition of lipolysis by oxytocin and vasopressin","author":"Fabian","year":"1977","journal-title":"Acta Univ Carol Med Monogr"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib73","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140848","article-title":"Vasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptor","volume":"6","author":"Andres-Hernando","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpet.2026.104936_bib74","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fendo.2019.00422","article-title":"Magnocellular vasopressin and the mechanism of \u201cGlucocorticoid Escape\u201d","volume":"10","author":"Antoni","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jpet.2026.104936_bib75","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2891-7-10","article-title":"The underlying mechanisms for development of hypertension in the metabolic syndrome","volume":"7","author":"Yanai","year":"2008","journal-title":"Nutr J"},{"issue":"3","key":"10.1016\/j.jpet.2026.104936_bib76","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1113\/jphysiol.1895.sp000565","article-title":"On the physiological action of extracts of pituitary body and certain other glandular organs: preliminary communication","volume":"18","author":"Oliver","year":"1895","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104936_bib77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/JOE-19-0168","article-title":"Chronic hypercortisolism causes more persistent visceral adiposity than HFD-induced obesity","volume":"242","author":"Garc\u00eda-Eguren","year":"2019","journal-title":"J Endocrinol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s42000-018-0023-7","article-title":"Chronic stress and body composition disorders: implications for health and disease","volume":"17","author":"Stefanaki","year":"2018","journal-title":"Hormones (Athens)"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4093\/dmj.2021.0280","article-title":"Insulin resistance: from mechanisms to therapeutic strategies","volume":"46","author":"Lee","year":"2022","journal-title":"Diabetes Metab J"},{"issue":"4","key":"10.1016\/j.jpet.2026.104936_bib80","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/joim.12649","article-title":"Vasopressin and metabolic disorders: translation from experimental models to clinical use","volume":"282","author":"Nakamura","year":"2017","journal-title":"J Intern Med"},{"key":"10.1016\/j.jpet.2026.104936_bib81","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.3389\/fphys.2018.01885","article-title":"Skeletal muscle: a significant novel neurohypophyseal hormone-secreting organ","volume":"9","author":"Adamo","year":"2019","journal-title":"Front Physiol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104936_bib82","first-page":"498","article-title":"Identification by RT-PCR and immunolocalization of arginine vasopressin in rat pancreas","volume":"25","author":"M\u00e9chaly","year":"1999","journal-title":"Diabetes Metab"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib83","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13578-024-01288-4","article-title":"V1bR enhances glucose-stimulated insulin secretion by paracrine production of glucagon which activates GLP-1 receptor","volume":"14","author":"Yun","year":"2024","journal-title":"Cell Biosci"},{"issue":"3","key":"10.1016\/j.jpet.2026.104936_bib84","doi-asserted-by":"crossref","first-page":"E127","DOI":"10.1152\/ajpendo.00269.2016","article-title":"Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V1A receptors","volume":"312","author":"Taveau","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jpet.2026.104936_bib85","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00125-015-3496-9","article-title":"Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats","volume":"58","author":"Taveau","year":"2015","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.jpet.2026.104936_bib86","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1210\/en.2006-1315","article-title":"Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice","volume":"148","author":"Aoyagi","year":"2007","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib87","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3945\/ajcn.2008.26382","article-title":"Relation between human vasopressin 1a gene variance, fat intake, and diabetes","volume":"89","author":"Enh\u00f6rning","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"Pt 1","key":"10.1016\/j.jpet.2026.104936_bib88","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1113\/jphysiol.2007.136481","article-title":"Insulin hypersensitivity in mice lacking the V1b vasopressin receptor","volume":"584","author":"Fujiwara","year":"2007","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib89","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbrc.2010.12.126","article-title":"Enhanced glucose tolerance in the Brattleboro rat","volume":"405","author":"Nakamura","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.jpet.2026.104936_bib90","first-page":"442","article-title":"Elevated serum oxytocin of the vasopressin-deficient Brattleboro rat is present throughout life and is not sensitive to treatment with vasopressin","volume":"117","author":"Boer","year":"1988","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"8","key":"10.1016\/j.jpet.2026.104936_bib91","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/jne.12047","article-title":"Oxytocin in Brattleboro rats: increased synthesis is contrasted by blunted intrahypothalamic release from supraoptic nucleus neurones","volume":"25","author":"Zelena","year":"2013","journal-title":"J Neuroendocrinol"},{"issue":"11","key":"10.1016\/j.jpet.2026.104936_bib92","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","article-title":"Metabolic inflammation and insulin resistance in obesity","volume":"126","author":"Wu","year":"2020","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.jpet.2026.104936_bib93","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2265.1985.tb00145.x","article-title":"The effect of vasopressin infusion on glucose metabolism in man","volume":"22","author":"Spruce","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jpet.2026.104936_bib94","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3389\/fendo.2018.00802","article-title":"Unraveling the regulation of hepatic gluconeogenesis","volume":"9","author":"Zhang","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.jpet.2026.104936_bib95","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cell.2007.01.021","article-title":"Chemical genetics: where genetics and pharmacology meet","volume":"128","author":"Knight","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jpet.2026.104936_bib96","doi-asserted-by":"crossref","unstructured":"Kamm O, Aldrich TB, Grote IW, Rowe LW, Bugbee EP. The active principles of the posterior lobe of the pituitary gland.1 I. The demonstration of the presence of two active principles. The separation of the two principles and their concentration in the form of potent solid preparations. J Am Chem Soc. 50(2):573\u2013601. doi:10.1021\/ja01389a050.","DOI":"10.1021\/ja01389a050"},{"issue":"4","key":"10.1016\/j.jpet.2026.104936_bib97","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/joim.12645","article-title":"Vasopressin: physiology, assessment and osmosensation","volume":"282","author":"Bankir","year":"2017","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib98","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13613-020-0628-2","article-title":"Vasopressin and its analogues in shock states: a review","volume":"10","author":"Demiselle","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib99","doi-asserted-by":"crossref","first-page":"F100","DOI":"10.1152\/ajprenal.00088.2008","article-title":"Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells","volume":"295","author":"Aoyagi","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104936_bib100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1476-5381.1989.tb11824.x","article-title":"Cardiovascular interactions between vasopressin, angiotensin and noradrenaline in the Brattleboro rat","volume":"96","author":"Laycock","year":"1989","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpet.2026.104936_bib101","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/bs.vh.2019.09.003","article-title":"Vasopressin actions in the kidney renin angiotensin system and its role in hypertension and renal disease","volume":"113","author":"Gonzalez","year":"2020","journal-title":"Vitam Horm"},{"issue":"4","key":"10.1016\/j.jpet.2026.104936_bib102","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1748-1716.2007.01722.x","article-title":"Losartan decreases vasopressin-mediated cAMP accumulation in the thick ascending limb of the loop of Henle in rats with congestive heart failure","volume":"190","author":"Torp","year":"2007","journal-title":"Acta Physiol (Oxf)"},{"issue":"3","key":"10.1016\/j.jpet.2026.104936_bib103","doi-asserted-by":"crossref","first-page":"F577","DOI":"10.1152\/ajprenal.00168.2010","article-title":"Interaction between vasopressin and angiotensin II in vivo and in vitro: effect on aquaporins and urine concentration","volume":"299","author":"Wang","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104936_bib104","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1053\/meta.2003.50047","article-title":"Angiotensin II upregulates the expression of vasopressin V2 mRNA in the inner medullary collecting duct of the rat","volume":"52","author":"Wong","year":"2003","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.jpet.2026.104936_bib105","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2174\/1871530321666210319120308","article-title":"Angiotensin II-vasopressin interactions in the regulation of cardiovascular functions. Evidence for an impaired hormonal sympathetic reflex in hypertension and congestive heart failure","volume":"21","author":"Iovino","year":"2021","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"2","key":"10.1016\/j.jpet.2026.104936_bib106","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41371-020-00467-3","article-title":"The mineralocorticoid receptor-an emerging player in metabolic syndrome?","volume":"35","author":"Thuzar","year":"2021","journal-title":"J Hum Hypertens"},{"issue":"3","key":"10.1016\/j.jpet.2026.104936_bib107","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1378\/chest.11-2604","article-title":"The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock","volume":"142","author":"Gordon","year":"2012","journal-title":"Chest"},{"issue":"2\u20133","key":"10.1016\/j.jpet.2026.104936_bib108","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2006.12.010","article-title":"Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice","volume":"559","author":"Hiroyama","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2026.104936_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115265","article-title":"Melatonin alleviates arginine vasopressin-induced cardiomyocyte apoptosis via increasing Mst1-Nrf2 pathway activity to reduce oxidative stress","volume":"206","author":"Chen","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/1570159X17666190717150501","article-title":"Vasopressin & oxytocin in control of the cardiovascular system: an updated review","volume":"18","author":"Japund\u017ei\u0107-\u017digon","year":"2020","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104936_bib111","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4070\/kcj.2021.0328","article-title":"Lifestyle modification in the management of metabolic syndrome: statement from Korean Society of CardioMetabolic Syndrome (KSCMS)","volume":"52","author":"Kim","year":"2022","journal-title":"Korean Circ J"},{"issue":"Suppl 1","key":"10.1016\/j.jpet.2026.104936_bib112","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000515021","article-title":"A journey through the early evidence linking hydration to metabolic health","volume":"76","author":"Vanhaecke","year":"2020","journal-title":"Ann Nutr Metab"},{"issue":"Suppl 2","key":"10.1016\/j.jpet.2026.104936_bib113","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/nutrit\/nuv038","article-title":"Acute and chronic effects of hydration status on health","volume":"73","author":"El-Sharkawy","year":"2015","journal-title":"Nutr Rev"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib114","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13366","article-title":"The nutrition transition to a stage of high obesity and noncommunicable disease prevalence dominated by ultra-processed foods is not inevitable","volume":"23","author":"Popkin","year":"2022","journal-title":"Obes Rev"},{"issue":"10","key":"10.1016\/j.jpet.2026.104936_bib115","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.3390\/nu10101502","article-title":"High fat\/high glucose diet induces metabolic syndrome in an experimental rat model","volume":"10","author":"Moreno-Fern\u00e1ndez","year":"2018","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jpet.2026.104936_bib116","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/10408398.2017.1363710","article-title":"Sodium status and the metabolic syndrome: a systematic review and meta-analysis of observational studies","volume":"59","author":"Soltani","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.jpet.2026.104936_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2023.112108","article-title":"The high salt intake in adults with metabolic syndrome is related to increased waist circumference and blood pressure: the Brazilian Longitudinal Study of Adult Health study (ELSA-Brasil)","volume":"114","author":"Ribeiro","year":"2023","journal-title":"Nutrition"},{"issue":"9","key":"10.1016\/j.jpet.2026.104936_bib118","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3390\/nu11091987","article-title":"Dietary fructose and the metabolic syndrome","volume":"11","author":"Taskinen","year":"2019","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.jpet.2026.104936_bib119","doi-asserted-by":"crossref","first-page":"E1065","DOI":"10.1210\/jc.2010-2981","article-title":"Plasma copeptin, a unifying factor behind the metabolic syndrome","volume":"96","author":"Enh\u00f6rning","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.jpet.2026.104936_bib120","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/cvr\/cvac160","article-title":"High salt intake activates the hypothalamic-pituitary-adrenal axis, amplifies the stress response, and alters tissue glucocorticoid exposure in mice","volume":"119","author":"Costello","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.jpet.2026.104936_bib121","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2337\/dc10-0987","article-title":"Sedentary activity associated with metabolic syndrome independent of physical activity","volume":"34","author":"Bankoski","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jpet.2026.104936_bib122","doi-asserted-by":"crossref","first-page":"R727","DOI":"10.1152\/ajpregu.00144.2008","article-title":"Influence of sedentary versus physically active conditions on regulation of plasma renin activity and vasopressin","volume":"295","author":"Mueller","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104936_bib123","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.npep.2014.09.006","article-title":"The influence of psychological stress on arginine vasopressin concentration in the human plasma and cerebrospinal fluid","volume":"48","author":"Bao","year":"2014","journal-title":"Neuropeptides"},{"issue":"5","key":"10.1016\/j.jpet.2026.104936_bib124","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/01.HYP.26.5.828","article-title":"Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism","volume":"26","author":"Burrell","year":"1995","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.jpet.2026.104936_bib125","first-page":"629","article-title":"Effect of a nonpeptide vasopressin V1 antagonist (OPC-21268) on experimental accelerated focal glomerulosclerosis","volume":"73","author":"Kurihara","year":"1996","journal-title":"Nephron"},{"issue":"10","key":"10.1016\/j.jpet.2026.104936_bib126","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/rheumatology\/39.10.1132","article-title":"Effect of SR 49059, a V1a vasopressin receptor antagonist, in Raynaud\u2019s phenomenon","volume":"39","author":"Hayoz","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.jpet.2026.104936_bib127","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.4088\/JCP.12m07804","article-title":"The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies","volume":"73","author":"Griebel","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.jpet.2026.104936_bib128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ndt\/gfv456","article-title":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice","volume":"31","author":"Gansevoort","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.jpet.2026.104936_bib129","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1471-0528.2000.tb13302.x","article-title":"Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea","volume":"107","author":"Brouard","year":"2000","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.jpet.2026.104936_bib130","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1124\/jpet.300.3.1122","article-title":"Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist","volume":"300","author":"Serradeil-Le Gal","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2026.104936_bib131","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1677\/JOE-07-0299","article-title":"Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes","volume":"196","author":"Iwen","year":"2008","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jpet.2026.104936_bib132","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3830380","article-title":"Central obesity is associated with variations in TSH and ACTH levels among euthyroid obese individuals","volume":"2022","author":"Lu","year":"2022","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.jpet.2026.104936_bib133","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1741-7015-11-44","article-title":"High-end normal adrenocorticotropic hormone and cortisol levels are associated with specific cardiovascular risk factors in pediatric obesity: a cross-sectional study","volume":"11","author":"Prodam","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.jpet.2026.104936_bib134","first-page":"57","article-title":"Tolvaptan, hyponatremia, and heart failure","volume":"4","author":"Zmily","year":"2011","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"7","key":"10.1016\/j.jpet.2026.104936_bib135","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1681\/ASN.2020101512","article-title":"The effect of tolvaptan on BP in polycystic kidney disease: a post hoc analysis of the TEMPO 3:4 trial","volume":"32","author":"Heida","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib136","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.kint.2018.11.044","article-title":"Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease","volume":"96","author":"Gansevoort","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.jpet.2026.104936_bib137","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0008-6363(02)00244-4","article-title":"Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V(1a) and V(2) receptor blockade and ACE inhibition","volume":"54","author":"Naitoh","year":"2002","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.jpet.2026.104936_bib138","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4103\/2230-8210.93734","article-title":"Vasopressin receptor antagonists and their role in clinical medicine","volume":"16","author":"Narayen","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.jpet.2026.104936_bib139","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.554961","article-title":"Multi-target approaches in metabolic syndrome","volume":"11","author":"Lillich","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2026.104936_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1390248","article-title":"Editorial: benefits and risks of drug combination therapy for chronic metabolic diseases","volume":"15","author":"Qiu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:22:25Z","timestamp":1785874945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526011353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":139,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0022356526011353"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104936","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arginine vasopressin: A promising therapeutic target for metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104936"}}